首页|心房颤动合并肿瘤治疗管理的双向影响现状

心房颤动合并肿瘤治疗管理的双向影响现状

扫码查看
随着全球老龄化,心房颤动(AF)及肿瘤的发病率均逐渐增高,AF逐渐成为肿瘤患者临床心血管疾病就诊咨询的常见原因。目前关于AF合并肿瘤的现有研究尚少,疾病治疗亦存在争议。基于现有研究证据,现综述归纳了 AF合并肿瘤的流行病学特征及生理学机制,总结了目前患者的临床管理策略,并指出了当前研究中存在的空白,以期为这一特定群体的规范治疗提供帮助。
Current Status of Bidirectional Effects of Therapeutic Management of Atrial Fibrillation Combined with Neoplasm
With global ageing,the incidence of atrial fibrillation(AF)and neoplasm is increasing,and AF is becoming a common cause of clinical cardiovascular consultation in the neoplasm patients.However,there is a paucity of studies on AF combined with neoplasm,and the treatment of the disease is controversial.Based on the available research evidence,this review summarized the epidemiological features and physiological mechanisms of AF combined with neoplasm,summarized the current clinical management strategies for patients with AF combined with neoplasm,and pointed out the gaps in current research to contribute to the standard treatment for this specific group.

Atrial fibrillationNeoplasmCardio-oncology

漆峰林、王恩润、肖骅

展开 >

重庆医科大学附属第一医院心血管内科,重庆 400016

心房颤动 肿瘤 心脏肿瘤学

重庆市自然科学基金

CSTB2023NSCQ-MSX0491

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(9)